A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

Clinical trial NCT05261191 · COMPLETED

Trial details

NCT number: NCT05261191
Sponsor: MacroGenics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus I Infection Immunodeficiency Virus Type 1, Human Human Immunodeficiency Virus Type 1

Start date: 2022-09-26
Primary completion: 2024-05-29
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.